Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001114220-18-000059)

Filing Details

Accession Number:: 0001114220-18-000059
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-31 16:19:48
Reporting Period:: 2018-05-29

Accepted Time:: 2018-05-31 16:19:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1114220	Keryx Biopharmaceuticals Inc	KERX	Pharmaceutical Preparations (2834)	134087132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1379970	C Steven Gilman	C/O Keryx Biopharmaceuticals, Inc. One Marina Park Drive, 12Th Floor Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-05-29	1,333	$5.22	18,667	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Sale of a total of 1,333 shares of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.
Includes 13,333 shares of restricted stock.